| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/28/2002 | EP0741741B1 Modified oligonucleotides |
| 08/28/2002 | EP0716607B1 Biochemically balanced peritoneal dialysis solutions |
| 08/28/2002 | EP0700284B1 Controlled release oxybutynin formulations |
| 08/28/2002 | CN1366527A Process for preparation of 3-vinylcephem compound |
| 08/28/2002 | CN1366524A Sulfonamide derivative as matrix metalloproteinase inhibitor |
| 08/28/2002 | CN1366521A Substituted 1-aza-2-imino heterocycles and their use as nicotinic acetylcholine receptors activators |
| 08/28/2002 | CN1366520A Medicine |
| 08/28/2002 | CN1366519A Phenoxazine compounds, its pharmaceutical compositions and medical use |
| 08/28/2002 | CN1366518A Biphenyl butyric acid derivative as matrix metalloproteinase inhibitor |
| 08/28/2002 | CN1366461A Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as active ingredient |
| 08/28/2002 | CN1366460A Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as active ingredient |
| 08/28/2002 | CN1366459A Preventive or therapeutic drugs for various eosinophilia-realated diseases containing chymase inhibitors as active ingredient |
| 08/28/2002 | CN1366458A Hair growth and hair formation controlling agents |
| 08/28/2002 | CN1365973A New cycloheplene compound, its preparation method and medicine composition containing same |
| 08/28/2002 | CN1365827A Exterior-applied medicine for treating osteopathy |
| 08/28/2002 | CN1365667A Use of phytanic acid for treating diabetes |
| 08/28/2002 | CN1365666A Composition for treating bronchial asthma and allergic rhinitis |
| 08/28/2002 | CN1365665A Synergistic composition containing ascobic acid salt and lysine used for diseases related with extracellular substrate degeneration |
| 08/28/2002 | CN1365664A Medicine for removing vegetation from human body and its preparing process and application |
| 08/28/2002 | CN1365663A Durably antibacterial and deodouring medicine for treating tinea manuum and tinea pedis |
| 08/28/2002 | CN1365662A Method of reducing appearance of black colour at lower part of eye |
| 08/28/2002 | CN1365614A Technique for detoxicating white spot syndrome virus of prawn |
| 08/28/2002 | CN1089765C 1H-pyrido [3,4-b] indole-4-carboxamide derivatives, preparation and application thereof in therapeutics |
| 08/28/2002 | CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 08/28/2002 | CN1089763C Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 08/28/2002 | CN1089762C Benzimidazole compounds and their use as modulators of GABAA receptor complex |
| 08/28/2002 | CN1089761C Sidechain-bearing texanes and its preparing process |
| 08/28/2002 | CN1089759C Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 08/28/2002 | CN1089755C Distamycin derivatives, processe for preparing them, and their use as antitumor and antiviral agents |
| 08/28/2002 | CN1089607C Immunomodulatory complex for helicobacter bacteria |
| 08/28/2002 | CN1089603C Liquid medicine for treating diseases of eye, ear, nose and throat |
| 08/28/2002 | CN1089593C Chinese medicinal preparation for treatment of toothache and method for preparation thereof |
| 08/28/2002 | CN1089588C Gargarism for treating oral diseases |
| 08/28/2002 | CN1089586C (5-androstene-17-one-3 beta hydroxyl) diacid ester, and its pharmaceutical use |
| 08/28/2002 | CN1089585C Use of levobupivacaine in facial surgery |
| 08/28/2002 | CN1089584C Treatment for arteriosclerosis and vitiligoidea |
| 08/28/2002 | CN1089583C Mycophenolate mofetil high dose oral suspensions |
| 08/28/2002 | CN1089581C Pharmaceutical preparation comprising lyophilized lipsomes encapsulating active principle which is highly insoluble in water, and process for preparing said preparation |
| 08/28/2002 | CN1089546C Method for raising pigs and promoting them stronger |
| 08/27/2002 | US6441212 Silanol enzyme inhibitors |
| 08/27/2002 | US6441207 Method for making hydroxy-25-ene-vitamin D compounds |
| 08/27/2002 | US6441193 Intermediates such as 1-(2-(4-(6-methoxy-3,4-dihydronaphtha-len-1-yl)phenoxy)ethyl)pyrrolidine and compounds such as cis-6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol, hydrobromide salt |
| 08/27/2002 | US6441188 Aminoaryl oxazolidinone N-oxides |
| 08/27/2002 | US6441186 Epothilone analogs |
| 08/27/2002 | US6441185 Method for producing thiazolidinediones, and new thiazolidinediones |
| 08/27/2002 | US6441184 Such as n-benzooxazol-2-yl-3-cyclopentyl-2-(4-methanesulfonyl -phenyl)-propionamide for increasing insulin secretion in the treatment of type ii diabetes |
| 08/27/2002 | US6441183 Useful as an intermediate in the preparation of certain small molecules that are useful in therapy or prophylaxis of inflammatory and immune cell-mediated diseases |
| 08/27/2002 | US6441180 Tetrazolyl-phenyl actamide glucokinase activators |
| 08/27/2002 | US6441179 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 08/27/2002 | US6441177 (4-bromo-phenyl)-(4-(6-(cyclopropyl-methyl-amino)-hexyloxy)-2-fluoro -phenyl)-methanone; antimycotic and cholesterol lowering activity |
| 08/27/2002 | US6441176 Method for preparing sodium-hydrogen exchanger type 1 inhibitor |
| 08/27/2002 | US6441173 Process for preparing indane carboxylate and cyclopentano [6] pyridine derivatives |
| 08/27/2002 | US6441168 Stable crystalline salts of 5-methyltetrahydrofolic acid |
| 08/27/2002 | US6441165 Process for the preparation of 11-amino-3-chloro-6, 11-dihydro-5, 5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine and application to the synthesis of tianeptine |
| 08/27/2002 | US6441163 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| 08/27/2002 | US6441162 Crystalline substance of cefditoren pivoxyl and the production of the same |
| 08/27/2002 | US6441153 Human carboxypeptidases and polynucleotides encoding the same |
| 08/27/2002 | US6441053 Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same |
| 08/27/2002 | US6441050 Palatable oral coenzyme Q liquid |
| 08/27/2002 | US6441049 Administering compound effective to inhibit binding of an amyloid beta peptide with alpha-7 nicotinic acetylcholine receptors |
| 08/27/2002 | US6441048 Methods of treating affective disorders using derivatives of (-)-venlafaxine |
| 08/27/2002 | US6441047 Glutamate antagonist and an intraocular pressure lowering agent |
| 08/27/2002 | US6441046 Control of metabolism |
| 08/27/2002 | US6441042 Hydroxamic acid derivatives as antibacterials |
| 08/27/2002 | US6441041 Oral administration, controlled release of hydroxycitric acid in its free-acid, amide, ester, lactone or salt form to treat bone mineral loss |
| 08/27/2002 | US6441040 200 parts s-(3-hydroxypropyl)-l-cysteine, 78 parts corn starch, 1 part talc, and 1 part magnesium stearate does not discolor after 12 months at room temperature, or 3 months at 40 degree c, or 1 month at 50 degree c |
| 08/27/2002 | US6441039 Gastro-intestinal adverse effect-free composition comprising an L-carnitine replacement |
| 08/27/2002 | US6441038 Treatment of fatigue, head injury and stroke |
| 08/27/2002 | US6441036 Treating atherosclerosis and insulin resistance |
| 08/27/2002 | US6441035 Administering to a mammal for the treatment of dry eye or other disorders requiring the wetting of the eye a heteroatom such as nitrogen, oxygen or sulfur interrupted hydroxyeicosatetraenoic acid related compounds |
| 08/27/2002 | US6441033 11β-fluoro 15β-hydroxy PGF2α analogs as FP receptor antagonists |
| 08/27/2002 | US6441032 Treating systemic lupis and multiple sclerosis |
| 08/27/2002 | US6441030 3-phenyl-pyrones |
| 08/27/2002 | US6441029 D-.gamma.-tocotrienol, 2-desmethyltocotrienol, d-.delta.-tocotrienol or d-tocotrienol and lovastatin |
| 08/27/2002 | US6441027 Administering o-chloroacetylcarbamoyl fumagillol |
| 08/27/2002 | US6441026 And an alkylating agent, an antimetabolite, a spindle poison, an epidophyllotoxin, an antibiotic, an enzyme, a topoisomerase inhibitor, a platinum coordination complex, a biological response modifier or a growth factor inhibitor |
| 08/27/2002 | US6441025 Water soluble paclitaxel derivatives |
| 08/27/2002 | US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection |
| 08/27/2002 | US6441021 Type-iv collagenase inhibitors |
| 08/27/2002 | US6441019 Cyclocarbamate and cyclic amide derivatives |
| 08/27/2002 | US6441017 Inhibitors of prenyl-protein transferase |
| 08/27/2002 | US6441015 Tetrazole compounds as thyroid receptor ligands |
| 08/27/2002 | US6441014 Antiinflammatory agent, useful for treating cylcoocygenase-2 associated disorders |
| 08/27/2002 | US6441013 5-ht6 receptor antagonists for treating central nervous system disorders |
| 08/27/2002 | US6441012 Chemical compounds |
| 08/27/2002 | US6441011 Combined preparation consisting of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol |
| 08/27/2002 | US6441010 Bi-aromatic compounds linked via a heteroethynylene radical, and pharmaceutical and cosmetic compositions containing them |
| 08/27/2002 | US6441009 Carboxyl pyridine derivatives chelate and inactivate the metals which can be carcinogenic or poisonous |
| 08/27/2002 | US6441008 Benzamide derivatives as thrombin inhibitors |
| 08/27/2002 | US6441007 Treating central nervous system disorders with pyridyloxylalkylamines and phenoxyalkylamines |
| 08/27/2002 | US6441006 Pharmaceutical compositions and methods for use |
| 08/27/2002 | US6441005 Oxazolidinone compounds and compositions, and methods of using the same |
| 08/27/2002 | US6441004 Monocyte chemoattractant protein-1 inhibitor compounds |
| 08/27/2002 | US6441002 The potent and selective cyclooxygenase-2 (cox-2) inhibitor etoricoxib |
| 08/27/2002 | US6441000 Compounds useful in therapy |
| 08/27/2002 | US6440998 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative |
| 08/27/2002 | US6440997 −E-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethylpiperidine, and its antidiarrhoeal use |
| 08/27/2002 | US6440996 Monomeric and dimeric heterocycles, and therapeutic uses thereof |
| 08/27/2002 | US6440995 Quinolin-4-yl derivatives |
| 08/27/2002 | US6440994 Method of treating acne |